|
Coustan-Smith, Elaine; Song, Guangchun; Shurtleff, Sheila et al. (2018) Universal monitoring of minimal residual disease in acute myeloid leukemia. JCI Insight 3:
|
|
Pauley, Jennifer L; Panetta, John C; Crews, Kristine R et al. (2013) Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments. Cancer Chemother Pharmacol 72:369-78
|
|
Faham, Malek; Zheng, Jianbiao; Moorhead, Martin et al. (2012) Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia. Blood 120:5173-80
|
|
Bhojwani, D; Pei, D; Sandlund, J T et al. (2012) ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy. Leukemia 26:265-70
|
|
Coustan-Smith, Elaine; Song, Guangchun; Clark, Christopher et al. (2011) New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood 117:6267-76
|
|
Pounds, Stan; Cao, Xueyuan; Cheng, Cheng et al. (2011) Integrated analysis of pharmacologic, clinical and SNP microarray data using Projection Onto the Most Interesting Statistical Evidence with Adaptive Permutation Testing. Int J Data Min Bioinform 5:143-57
|
|
Pui, Ching-Hon; Pei, Deqing; Campana, Dario et al. (2011) Improved prognosis for older adolescents with acute lymphoblastic leukemia. J Clin Oncol 29:386-91
|
|
Stow, Patricia; Key, Laura; Chen, Xiaohua et al. (2010) Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia. Blood 115:4657-63
|
|
Morris, Van K; Spraker, Holly L; Howard, Scott C et al. (2010) Severe thrombocytopenia with iron deficiency anemia. Pediatr Hematol Oncol 27:413-9
|
|
Campana, Dario (2010) Minimal residual disease in acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2010:7-12
|
Showing the most recent 10 out of 71 publications
